Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis
dc.contributor.author | Medeiros, Cely Saad Abboud | pt_BR |
dc.contributor.author | Rao, Gauri G. | pt_BR |
dc.contributor.author | Souza, Ercilia Evangelista de | pt_BR |
dc.contributor.author | Zavascki, Alexandre Prehn | pt_BR |
dc.contributor.author | Kiffer, Carlos Roberto Veiga | pt_BR |
dc.date.accessioned | 2019-10-11T03:55:06Z | pt_BR |
dc.date.issued | 2018 | pt_BR |
dc.identifier.issn | 1413-8670 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/200515 | pt_BR |
dc.description.abstract | A retrospective cohort study, were evaluated: polymyxin B plus aminoglycosides orpolymyxin B plus other antibiotics. Any degree of acute kidney injury occurred in 26 (86.6%)patients. The median time to acute kidney injury was 6.0 (95% CI 3–14) days in the polymyxin-aminoglycoside containing regimen group, against 27.0 (95% CI 6–42) days in the polymyxinwith other antimicrobial combinations group (p = 0.03). Polymyxin B with aminoglycosidesgroup progressed faster to any degree of renal dysfunction. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | The Brazilian journal of infectious diseases. Salvador. vol. 22, no. 1 (Jan./Feb. 2018), p. 51-54 | pt_BR |
dc.rights | Open Access | en |
dc.subject | Lesão renal aguda | pt_BR |
dc.subject | Enterobacteriáceas resistentes a carbapenêmicos | pt_BR |
dc.title | Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 001091520 | pt_BR |
dc.type.origin | Nacional | pt_BR |
Este item está licenciado na Creative Commons License
-
Artigos de Periódicos (39559)Ciências da Saúde (10608)